Stefan Schmidt

Innsbruck, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

"It has become clearer where it is unsteady, where it is stable" - Lessons to learn from the restrictions of the therapeutic environment in the Covid-19-pandemic for in-patient psychotherapy

"It has become clearer where it is unsteady, where it is stable" - Lessons to learn from the restrictions of the therapeutic environment in the Covid-19-pandemic for in-patient psychotherapy

Journal: Psychiatrische Praxis

Published: March 19, 2026

Cellular expression of PD-1, PD-L1 and CTLA-4 in patients with JAK2V617F mutated myeloproliferative disorders.

Cellular expression of PD-1, PD-L1 and CTLA-4 in patients with JAK2V617F mutated myeloproliferative disorders.

Journal: Clinical chemistry and laboratory medicine

Published: March 13, 2025

Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q.

Real-World Data on the Efficacy of Daratumumab in Patients with Relapsed/Refractory Multiple Myeloma and Amplification 1q.

Journal: Cancers

Published: February 20, 2025

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.

ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options.

Journal: Annals of hematology

Published: January 12, 2024

Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.

Efficacy and safety of tixagevimab/cilgavimab as passive immunisation against COVID-19 infections in patients with hematological malignancies.

Journal: Annals of hematology

Published: November 20, 2023

What's new in myeloproliferative neoplasia?

What's new in myeloproliferative neoplasia?

Journal: Deutsche medizinische Wochenschrift (1946)

Published: March 15, 2022

Most healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis.

Most healthcare interventions tested in Cochrane Reviews are not effective according to high quality evidence: a systematic review and meta-analysis.

Journal: Journal of clinical epidemiology

Published: January 24, 2022

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.

Serologic Responses to COVID-19 Vaccines in Hematological Patients Are Predominantly Impaired in Lymphoid but not in Myeloid Malignancies.

Journal: HemaSphere

Published: November 23, 2021

Mindfulness-based and acceptance-based programmes in the treatment of obsessive-compulsive disorder: a study protocol for a systematic review and meta-analysis.

Mindfulness-based and acceptance-based programmes in the treatment of obsessive-compulsive disorder: a study protocol for a systematic review and meta-analysis.

Journal: BMJ open

Published: June 26, 2021

Alterations in the Experience of Time, Space, and Intersubjectivity and the Interaction with Pre-Existent Psychopathology during the COVID-19 Pandemic.

Alterations in the Experience of Time, Space, and Intersubjectivity and the Interaction with Pre-Existent Psychopathology during the COVID-19 Pandemic.

Journal: Psychopathology

Published: June 14, 2021

Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.

Upregulation of Checkpoint Ligand Programmed Death-Ligand 1 in Patients with Paroxysmal Nocturnal Hemoglobinuria Explained by Proximal Complement Activation.

Journal: Journal of immunology (Baltimore, Md. : 1950)

Published: January 13, 2021

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events.

Journal: Blood advances

Published: December 18, 2020

Showing 1-12 of 25

Last Updated: 09/26/2026